All In Biotech

Free tool

FAERS Monitor: Arnuity Ellipta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205625 or its brand name (Arnuity Ellipta, Fluticasone Furoate). Reports on generic versions are filed under their own applications.

Reports

9,896

Serious

6,929

70% of reports

Hospitalization

2,819

Death reported

616

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,572
  • drug ineffective1,570
  • asthma1,315
  • off label use926
  • cough911
  • wheezing908
  • therapeutic product effect incomplete766
  • nausea686
  • pain665
  • pneumonia661
  • macular degeneration632
  • malaise620
  • headache600
  • vomiting584
  • fatigue561

Reports by year received

View as table
YearReports
20071
20084
20093
201017
201152
2012266
201343
201476
2015156
2016219
2017423
2018583
2019690
2020852
20211,246
20221,096
20231,134
20241,145
20251,105
2026785

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,263 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
macular degenerationSignal632118.7109.869,779
wheezingSignal90833.031.027,821
asthmaSignal1,31525.023.830,096
therapeutic product effect incompleteSignal76623.121.616,072
coughSignal9116.96.54,658
dyspnoeaSignal1,5725.95.76,576
pneumoniaSignal6614.34.01,723
malaiseSignal6203.02.8845
vomitingSignal5842.62.4607
drug ineffectiveSignal1,5702.52.41,552
painSignal6652.32.1503
off label useSignal9262.22.1668
headacheSignal6002.01.9324
nausea6861.81.7274
fatigue5611.51.4107

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.